Scientific publications

Clonal transmission of NDM-5-producing Escherichia coli belonging to high-risk sequence type ST405
Barrado L (1), Pérez-Vázquez M (2), Luis Del Pozo J (3), Martín-Salas C (4), Leiva J (5), Mazón A (4), Ezpeleta C (4), Oteo J (6).
(1) Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Navarra, Spain.
(2) Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016), Instituto de Salud Carlos III, Madrid, Spain.
(3) Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Navarra, Spain; Área de Enfermedades Infecciosas, Clínica Universidad de Navarra, Pamplona, Navarra, Spain; Servicio de Microbiología y Parasitología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
(4) Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Navarra, Spain; Servicio de Microbiología, Complejo Hospitalario de Navarra, Pamplona, Navarra, Spain.
(5) Instituto de Investigación Sanitaria de Navarra (IdiSNa), Pamplona, Navarra, Spain; Servicio de Microbiología y Parasitología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain.
(6) Laboratorio de Referencia e Investigación en Resistencia a Antibióticos e Infecciones relacionadas con la Asistencia Sanitaria, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain; Spanish Network for Research in Infectious Diseases (REIPI RD16/0016), Instituto de Salud Carlos III, Madrid, Spain.
Magazine: International Journal of Antimicrobial Agents
Date: Jun 1, 2018
Clinical Microbiology [SP]Sir,
Carbapenemase-producing Enterobacteriaceae are a critical public-health problem. The European Survey on Carbapenemase-Producing Enterobacteriaceae (EuSCAPE) reported that 19% of carbapenem-non-susceptible Escherichia coli isolates produced carbapenemases [1].
In Spain, an upward trend in carbapenemase-producing E. coli has been observed, mainly due to the dissemination of OXA-48 [2]; however, sporadic occurrence of NDM-producers has been reported [2] ; [3].
The success of high-risk E. coli clones might be due to factors such as increased transmission and colonisation capacity, antibiotic multiresistance and enhanced virulence.
CITATION Int J Antimicrob Agents. 2018 Jun 1. pii: S0924-8579(18)30156-0. doi: 10.1016/j.ijantimicag.2018.05.018.
you mayBE INTERESTED
WHAT TECHNOLOGY
DO WE USE?
The Clínica is the greater private hospital with technological equipment of Spain, all in a single center.

OUR
PROFESSIONALS
The professionals of the Clínica perform continuous research and training, always to the benefit of the patient.

WHY CHOOSE
THE CLINICA?
Learn why we are different from other healthcare centers. Quality, speed, comfort and results.
